logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (viii) All inpatient clients, primary drug distribution by age (%)

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids4.224.243.859.464.361.757.041.21609837
Cocaine1.42.96.07.68.810.911.17.923783
Stimulants11.320.516.310.89.17.810.110.8360826
Hypnotics and sedatives1.42.42.63.03.54.47.922.4153815
Hallucinogens0.00.30.40.30.30.10.00.0750
Volatile substances23.97.31.00.80.70.50.20.23650
Cannabis 53.537.723.313.39.810.49.19.3470113
Other substances 4.24.86.54.83.64.14.68.115430
Total7121656216769658953477232524613030694

Notes:

 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011